Early research (Phase 1)Study completedNCT01158274
What this trial is testing
RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors
Who this might be right for
Adult Grade III Lymphomatoid GranulomatosisAdult Nasal Type Extranodal NK/T-cell LymphomaAIDS-related Diffuse Large Cell Lymphoma+83 more
National Cancer Institute (NCI) 30